Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neomed Institute
Montréal, Quebec, Canadaneomed.ca ↗
- Ownership
- Private
- Employees
- ~145
- Development stage
- Other
01
Overview
NEOMED Institute served as an incubator and R&D hub supporting proof-of-concept stage drug development for Canadian SMEs across small molecule, biologics, and vaccine modalities. It operated as an open-access platform, fostering partnerships and facilitating early-stage drug programs, rather than owning a proprietary drug pipeline. No active clinical pipeline or marketed drugs are directly attributable to this entity, as it hosted projects from other companies. It has since been acquired by adMare BioInnovations.
- Modalities
- Small moleculeBiologicVaccine
- Industry
- Drug Discovery Services
02
Partnerships
Beyond the preview
Go deeper on Neomed Institute.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neomed Institute.